Biotech in the military is inevitable.
Malet ’11/15 [David; 11/13/15; Qualifications; "Captain America in International Relations: the Biotech Revolution in Military Affairs," https://www-tandfonline-com.proxy.lib.umich.edu/doi/pdf/10.1080/14702436.2015.1113665?needAccess=true, IC]
The Biotech Revolution in Military Affairs There have been numerous studies of the impacts of a wide array of emergent technologies by hegemonic actors or aspirants (For a preliminary list, see Jervis 1978, Levy 1984, Posen 1984, Shimshoni 1990, Arquilla and Ronfeldt 1997, Adams 1998, Murray and Millett 1998, Tannenwald 2008, Clarke and Knake 2010, Vogel 2012, Waltz and Sagan 2012, Carpenter 2013). However, there has been little examination of what the adoption of biotechnology by the leading military powers has meant or is likely to mean. The United States Office of Technology Assessment defines biotechnology as “any technique that uses a living organism, or parts of organisms, to make or modify products, to improve plants or animals, or to develop microorganisms for specific uses.” 320 D. Malet Other definitions include material patterned after living organisms but not necessarily using them as components (biomimetics). The conventional wisdom on biotechnology has held that coming decades will see Western nations increasingly vulnerable to ever-more sophisticated biological weapons attacks by non-state actors and rogue states. As recombinant genetic technology proliferates, a greater number of actors will possess genetic engineering capabilities that will enhance the lethality and durability of their biological weapons. Proponents of this perspective note that the overwhelming technological advantage in conventional forces enjoyed by the United States creates the incentive for competitors to develop effective asymmetric responses, and that the affordability, accessibility, and relatively easy preparation of biological weapons make them a likely means of doing so. In this view, the superior conventional capabilities of the US military not only fail to deter the proliferation of biological weapons, but encourage their development. Western states will face an increasing number of biologically armed opponents, and will remain on the defensive. The priority for military biotech research is therefore the development of protective equipment and vaccines, antibiotics and antivirals (Department of Defense 1998). However, this scenario requires the presumption that military applications of biotechnology will simply be a secular progression from the bacteriological warfare that has existed throughout history. Even when analysts have factored in the vast possibilities of genetic engineering, it has usually only been to the extent that they can breed deadlier pathogens, and that the growing availability of technology means that it may be used by a broader spectrum of actors. Conventional wisdom therefore predicts an unstable future for the international system, a Hobbesian world in which the weakest have power to kill the strongest. Rather than rogue states and non-state terrorists, it is the most powerful and resource-laden actors in the international system that will enjoy the advantages of “biological warfare” in the twenty-first century as they continuously integrate emergent biotechnologies into their military and national defense infrastructures and extend their dominance. This process will closely resemble the Revolution in Military Affairs (RMA) that occurred during the last 30 years of the twentieth century as the United States adapted its forces to exploit advances in new information technologies. The RMA, first described by the Soviet military intelligence in the 1970s and then witnessed by the world during the unexpectedly uneven 1991 Gulf War, occurred because the United States employed its competitive advantage in integrated computer systems. Rather than a single transformative device, like the atomic bomb, the steady accretion of advanced technologies augmenting existing equipment came to inform doctrine and strategies. The term asymmetric warfare is meant to describe efforts by weaker participants in military confrontations to frustrate the advantages of the stronger power by guerilla tactics or other unconventional methods not envisioned in force planning (Mack 1975). However, high technology also offers asymmetric advantages to the best-equipped actors, and American military planners sought to use the advances of the RMA to field forces that no state competitor could match. Their goals included “dominant maneuver” capability on the battlefield in bringing dispersed resources to bear against targets, “precision engagement” capability delivered by smart weapons, and “full dimension force protection” against all anticipated threats (Rizwan 2000). The ultimate expression of this vision would be a fighter comparable to a “Jedi knight” from the Star Wars films: a super-empowered solider, dressed in a protective stealth cloak and commanding an Defence Studies 321 armed companion drone, able to perform solo missions and to transmit data back to headquarters (Hundley and Gritton 1994). Coincidentally or not, this is precisely how Darth Maul was depicted in 1999’s The Phantom Menace. Military planners likewise foresee similar advantages conferred by developments across the various biotech fields. In coming decades, biotechnology is forecast to bring advances such as “rugged computers” made from biological components that will provide situational awareness to individual soldiers on the battlefield, camouflaged materials and lightweight armor incorporating the properties of living organisms, and ingested biological markers to distinguish friendlies, which would be of particular use in counterinsurgency (Purdue University 2001). From the perspective of those involved in force planning, the anticipated future is not one of vulnerability but unassailability.